Opinions of Japanese and American ALS caregivers regarding tracheostomy with invasive ventilation (TIV)

Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
Georgia ChristodoulouJudith Rabkin

Abstract

Our objective was to learn more about possible factors contributing to the higher rates of tracheostomy with invasive ventilation (TIV) for ALS patients in Japan compared with the United States by eliciting attitudes of caregivers of ALS patients in both countries. One hundred and fifty-four American caregivers from five, geographically-distributed ALS clinics and 66 Japanese caregivers from six sites in Japan completed questionnaires regarding TIV. Results showed that 33% of American caregivers were in favor of TIV for their family member compared to 53% of Japanese caregivers; 44% of American and 37% of Japanese caregivers were undecided; and 22% of American and 10% of Japanese caregivers were opposed (p <.01). Within patient-caregiver dyads, agreement in the American sample was fair, while the Japanese dyads showed poor agreement. Maintaining quality of life and patients reaching a milestone were the most common reasons for favoring TIV in the American and Japanese samples, respectively. Reasons for opposing TIV did not significantly differ. Findings suggest that caregiver preferences may influence actual choices for ALS patients. More frequent endorsement of TIV by Japanese vs. American caregivers is consistent with higher ...Continue Reading

References

Jan 7, 1998·Journal of the Neurological Sciences·A SmythM Siegler
Sep 25, 1998·Journal of Neurology·G D BorasioN Yanagisawa
Aug 24, 2001·Journal of Neurology·C NeudertG D Borasio
Jul 23, 2002·Journal of General Internal Medicine·Shinji MatsumuraNeil Wenger
Jul 9, 2003·Neurology·Hideaki Hayashi, Edward Anthony Oppenheimer
Apr 1, 2004·BMC Family Practice·Miho SekimotoYuichi Imanaka
Oct 31, 2008·Journal of the Neurological Sciences·Naoki AtsutaUNKNOWN Research Committee on the Neurodegenerative Diseases of Japan
Feb 10, 2009·Rinshō shinkeigaku = Clinical neurology·Mieko Ogino
Jun 23, 2009·Journal of Pain and Symptom Management·Steven M AlbertHiroshi Mitsumoto
Jun 17, 2010·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·David J Oliver, Martin R Turner
Jun 19, 2010·Palliative & Supportive Care·Josée Lemoignan, Carolyn Ells
Jan 29, 2011·Journal of Critical Care·Andrea VianelloVittorino Salvador
Jan 5, 2012·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Douglas A McKimAndrew Woolnough
Apr 27, 2012·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Amy Y TsouJudith A Long
Sep 20, 2012·Journal of the Neurological Sciences·Rossella SpataroVincenzo La Bella
Oct 9, 2012·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Judith RabkinHiroshi Mitsumoto
Oct 12, 2013·The American Journal of Hospice & Palliative Care·Kazuhiro NakazawaTetsuhiro Maeno
Feb 22, 2014·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Kristen QutubEleanor Feingold
Apr 12, 2014·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Judith RabkinHiroshi Mitsumoto
Jul 16, 2014·Journal of the Neurological Sciences·Muneyoshi TagamiToshiaki Hanafusa
Dec 19, 2014·Journal of Intensive Care·Jun MakinoJohn Oropello

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.